An interventional study of slider neural mobilization techniques and tensioner neural mobilization in Carpal Tunnel Syndrome (CTS), sponsored by Prince Sattam Bin Abdulaziz University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Prince Sattam Bin Abdulaziz University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
neural mobilization techniques in carpal tunnel syndrome
Thirty patients with CTS will be randomly allocated to two equal groups of 15. Group A will receive slider median nerve mobilization techniques and Group B received tensioners median nerve mobilization techniques , twice a week for 10 weeks
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 446 interventional studies indexed under Carpal Tunnel Syndrome.
Browse Carpal Tunnel Syndrome studies →Prince Sattam Bin Abdulaziz University is the lead sponsor of 36 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
slider median nerve mobilization tecnique
Other: slider neural mobilization techniques
tensioner median nerve mobilization techniques
Other: tensioner neural mobilization
patients in group A recieve slider median nerve mobilization
patients in group recieve tensioner median nerve mobilization techniques
pain intensity
pain intensity will be measured by visual analogue scale
Time frame: 10 weeks
functional disability
it will be assessed by the arabic version of DASH questionnaire
Time frame: 10 weeks
hand grip strength
it will be assessed by HHD
Time frame: 10 WEEKS
Pressure pain threshold
It will be assessed by pressure algometry
Time frame: 10 weeks
No study locations are listed for this record.
Plan to share: No
Start is estimated for Dec 2026; primary completion for Apr 2027, 4 months later.
Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 4 months is below that.
Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Prince Sattam Bin Abdulaziz University